Q2 FY2026 · ended Jun 30, 2026 · Revenue $629,312, -9.8% YoY · Filed Aug 14, 2026
Stemtech Corporation (STEK) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $629,312 and a net loss of $292,358. Free cash flow was -$54,844. As of Jun 30, 2026 it held $246,772 in cash and investments and $4.4 million in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- STEK (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Naples, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1511820
- Former names
- Globe Net Wireless Corp. (until Sep 21, 2021)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $629,312 | $462,957 | $458,109 | $852,300 | $697,925 |
| Operating income | -$125,567 | -$1.1M | -$863,937 | -$339,217 | -$300,988 |
| Net income | -$292,358 | -$1.3M | -$1.5M | -$809,406 | -$293,145 |
| Diluted EPS | $0.00 | $0.00 | -$0.01 | -$0.01 | $0.00 |
| Operating cash flow | -$54,844 | -$425,883 | $127,001 | $24,971 | $74,952 |
| Free cash flow | -$54,844 | -$425,883 | $127,001 | $24,971 | $74,952 |
| Total assets | $3.2M | $3.3M | $3.1M | $3.8M | $3.9M |
| Total liabilities | $11.1M | $11.1M | $10.6M | $10.3M | $10.3M |
| Stockholders' equity | -$7.5M | -$7.3M | -$7.0M | -$5.8M | -$5.7M |
| Cash and investments | $246,772 | $256,149 | $238,245 | $255,416 | $272,450 |
| Total debt | $4.4M | $4.2M | $4.2M | $4.1M | $4.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Jun 22, 2026 | Mar 31, 2026 |
| 10-K | Annual report | May 29, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 19, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Jul 17, 2025 | Mar 31, 2025 |
All 159 Stemtech Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.